Category: Private Citizen — Corporate Director Role: Independent Director, UnitedHealth Group Inc. (UNH); Governance Committee Chair Board Tenure: 2019 – present Committee Memberships: Governance Committee (Chair); Compensation and Human Resources Committee; Health and Clinical Practice Policies Committee Profile Type: Board Member Accountability — Anchor B (Documented Organizational Leadership)

Basis for Inclusion: Dr. John Noseworthy holds a documented governance role as Governance Committee Chair and member of three governance committees at UnitedHealth Group Inc., which made documented political donations to Trump-aligned entities. As Governance Committee Chair, Noseworthy holds primary board-level responsibility for UnitedHealth’s governance framework, including director selection and corporate governance practices. This profile documents the factual governance relationship, not the subject’s personal political views.

Subject Classification: Private Citizen / Corporate Director. Board membership is a matter of public record (SEC filings, proxy statements). This profile documents only the governance role and its connection to documented corporate political activity.

Biographical Overview

John H. Noseworthy, M.D. served as President and CEO of Mayo Clinic from 2009 to 2018, leading one of the world’s most respected not-for-profit medical centers. He is a neurologist who specialized in multiple sclerosis and was editor of Neurology, the leading neurology journal, before taking on leadership roles at Mayo. After retiring as Mayo CEO, he has served on several corporate boards including Medtronic and Achieve Finance.

Noseworthy’s academic medical and healthcare leadership background gives him relevant clinical and operational expertise for overseeing a company of UnitedHealth’s scale and complexity. As Governance Committee Chair, he oversees board structure and practices that are currently under intense public scrutiny following the assassination of CEO Brian Thompson in December 2024, which focused national attention on UnitedHealth’s claims denial practices.

He holds an M.D. from Dalhousie University and completed neurology training at Dalhousie and the University of Vermont.

Board Role and Governance Authority

• Company: UnitedHealth Group Inc. (NYSE: UNH)
• Board tenure: 2019 – present
• Committee assignments: Governance Committee (Chair); Compensation and Human Resources Committee; Health and Clinical Practice Policies Committee

Parent Corporate Donor Profile

This profile is a governance-accountability companion to the UnitedHealth Group corporate donor profile, which documents the corporation’s political spending and regulatory relationships under the Trump administration.

Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@citizenanalyst.ai with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.

Investigative trail pointers (public records)

Education only — verify independently. Absence of hits is not proof.

Use public-records-research-specialist, corporate-intelligence-investigator, and public-corruption-ombudsman evidence tiers.

Sources

• UnitedHealth Group Inc. DEF 14A Proxy Statement, filed April 21, 2025; SEC EDGAR (CIK 731766)